Recognition underscores the impact of Proscia in advancing precision medicine from drug discovery to diagnostics PHILADELPHIA — June 3, 2025 — Proscia®, a software company accelerating pathology’s transition to digital and AI, today...

Next-gen sequencing leader joins microprocessing giant to apply genomics and AI technologies toward drug discovery, clinical research, and human health SAN FRANCISCO—Nvidia will partner with Illumina to apply genomics and AI technologies...

Proscia & Bioptimus: Explore how foundation models can transform novel AI development in pathology Unlocking the Promise of Foundation Models in Pathology for AI-Driven Drug Discovery & Development November 6, 11:00 AM — 12:00...

From the Paige blog: By now, AI’s ability to enhance diagnostic efficiency and reduce cancer detection errors is well documented, delivering benefits to pathologists and patients globally. Still, these outcomes are only the beginning of...

PathAI: Foundation models were developed on numerous diverse data and will enable drug discovery and anatomic pathology laboratory use cases BOSTON, MA / ACCESSWIRE / May 14, 2024 / PathAI, a global leader in AI-powered pathology, today...

PictorLabs Launches with More Than $18.8 Million to Advance Transformative Virtual Staining AI-powered virtual staining demonstrates potential to revolutionize histopathology, simplify lab workflows, and accelerate drug discovery Financing...